Storebrand Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,033
Closed -$8.5K 864
2022
Q4
$8.5K Hold
2,033
﹤0.01% 857
2022
Q3
$8.15K Sell
2,033
-6,521
-76% -$49.5K ﹤0.01% 855
2022
Q2
$96.7K Hold
8,554
﹤0.01% 794
2022
Q1
$139K Hold
8,554
﹤0.01% 785
2021
Q4
$405K Buy
8,554
+453
+6% +$27.2K ﹤0.01% 765
2021
Q3
$587K Buy
8,101
+3,139
+63% +$227K ﹤0.01% 749
2021
Q2
$417K Buy
+4,962
New +$327K ﹤0.01% 763

Other funds holding NBP

Storebrand Asset Management's NBP Position: Q1 2023 in Review

Storebrand Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 2,033 shares — an estimated $8.5K sold.

Storebrand Asset Management first reported a position in NBP in Q2 2021 and held it in 7 quarters. The position peaked at $587K in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

  • Storebrand Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Storebrand Asset Management sold 2,033 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $8.5K.
  • Storebrand Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 7 quarters.
  • Storebrand Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $587K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Storebrand Asset Management's 13F filing for Q1 2023, filed 18 Jun 2026.